IBM Tivoli Monitoring up to 6.2.2 FP9/6.2.3 FP5/6.3.0 FP6 Portal Client access control
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 9.9 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in IBM Tivoli Monitoring up to 6.2.2 FP9/6.2.3 FP5/6.3.0 FP6. It has been declared as problematic. Affected by this issue is some unknown functionality of the component Portal Client. Executing a manipulation can lead to access control. This vulnerability is handled as CVE-2015-7411. The attack can be executed remotely. There is not any exploit available.
Details
A vulnerability has been found in IBM Tivoli Monitoring up to 6.2.2 FP9/6.2.3 FP5/6.3.0 FP6 (Directory Service Software) and classified as critical. This vulnerability affects some unknown processing of the component Portal Client. The manipulation with an unknown input leads to a access control vulnerability. The CWE definition for the vulnerability is CWE-264. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
The portal client in IBM Tivoli Monitoring (ITM) 6.2.2 through FP9, 6.2.3 through FP5, and 6.3.0 through FP6 allows remote authenticated users to gain privileges via unspecified vectors.
The weakness was released 03/12/2016 (Website). The advisory is available at www-01.ibm.com. This vulnerability was named CVE-2015-7411 since 09/29/2015. The attack can be initiated remotely. Required for exploitation is a single authentication. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $5k-$25k at the moment (estimation calculated on 07/10/2022). It is expected to see the exploit prices for this product increasing in the near future.This vulnerability is assigned to T1068 by the MITRE ATT&CK project.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at Vulnerability Center (SBV-57361†). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 9.9VulDB Meta Temp Score: 9.9
VulDB Base Score: 9.9
VulDB Temp Score: 9.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 9.9
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
Timeline
09/29/2015 🔍03/11/2016 🔍
03/12/2016 🔍
03/13/2016 🔍
03/17/2016 🔍
07/10/2022 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2015-7411 (🔍)
GCVE (CVE): GCVE-0-2015-7411
GCVE (VulDB): GCVE-100-81346
SecurityTracker: 1035240
Vulnerability Center: 57361 - IBM Tivoli Monitoring Remote Code Execution Vulnerability, High
Entry
Created: 03/13/2016 11:54Updated: 07/10/2022 10:33
Changes: 03/13/2016 11:54 (54), 02/01/2019 14:37 (10), 07/10/2022 10:33 (2)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.